268
Views
68
CrossRef citations to date
0
Altmetric
Original Investigations

Increased xanthine oxidase in the thalamus and putamen in depression

, , , , , & show all
Pages 314-320 | Received 31 Jan 2008, Accepted 08 Apr 2008, Published online: 10 Mar 2010

References

  • Akaike T, Ando M, Oda T, Doi T, Ijiri S, Araki S, et al. Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest 1990; 85: 739–745
  • Aranda R, Doménech E, Rus AD, Real JT, Sastre J, Viña J, et al. Age-related increase in xanthine oxidase activity in human plasma and rat tissues. Free Radic Res 2007; 28: 1–6
  • Baumann B, Danos P, Krell D, Diekmann S, Leschinger A, Stauch R, et al. Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a post-mortem study. J Neuropsychiatry Clin Neurosci 1999; 11: 1–78
  • Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 2004; 555: 589–606
  • Bilici M, Efe H, Köroğlu MA, Uydu HA, Bekaroğlu M, Değer O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001; 64: 43–51
  • Brown JL, Terada LS, Grosso MA, Whitmann GJ, Velasco SE, Patt A, et al. Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts. J Clin Invest 1988; 81: 1297–1301
  • Caetano SC, Sassi R, Brambilla P, Harenski K, Nicoletti M, Mallinger AG, et al. MRI study of thalamic volumes in bipolar and unipolar patients and healthy individuals. Psychiatry Res 2001; 108: 161–168
  • Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry 2000; 48: 813–829
  • Durany N, Münch G, Michel TM, Riederer P. Investigations on oxidative stress and therapeutical implications in dementia. Eur Arch Psychiatry Clin Neurosci 1999; 249: 68–73
  • Emmerson BT. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi. Australasian Ann Med 1967; 16: 205–214
  • Ende G, Demirakca T, Walter S, Wokrina T, Sartorius A, Wildgruber D, et al. Subcortical and medial temporal MR-detectable metabolite abnormalities in unipolar major depression. Eur Arch Psychiatry Clin Neurosci 2006; 257: 36–39
  • Fridovich I. Biological effects of the superoxide radical. Arch Biochem Biophys 1986; 247: 1–11
  • Germain A, Nofzinger EA, Kupfer DJ, Buysse DJ. Neurobiology of non-REM sleep in depression: further evidence for hypofrontality and thalamic dysregulation. Am J Psychiatry 2004; 161: 1856–1863
  • Götz ME, Kunig G, Riederer P, Youdim MB. Oxidative stress: free radical production in neural degeneration. Pharmacol Ther 1994; 63: 37–122
  • Gok F, Ichida K, Topaloglu R. Mutational analysis of the xanthine dehydrogenase gene in a Turkish family with autosomal recessive classical xanthinuria. Nephrol Dial Transplant 2003; 18: 2278–2283
  • Grünblatt E, Mandel S, Jacob-Hirsch J, Zeligson S, Amariglo N, Rechavi G, et al. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm 2004; 111: 1543–1573
  • Grünblatt E, Schlösser R, Fischer P, Fischer MO, Li J, Koutsilieri E, et al. Oxidative stress related markers in the “VITA” and the centenarian projects. Neurobiol Aging 2005; 26: 429–438
  • Gsell W, Lange KW, Pfeuffer R, Heckers S, Heinsen H, Senitz D, et al. How to run a brain bank. A report from the Austro-German brain bank. J Neural Transm Suppl 1993; 39: 31–70
  • Guerciolini R, Szumlanski C, Weinshilboum RM. Human liver xanthine oxidase: nature and extent of individual variation. Clin Pharmacol Ther 1998; 50: 663–672
  • Halliwell B. Tell me about free radicals, doctor: a review. J R Soc Med 1989; 82: 747–752
  • Harrison R. Structure and function of xanthine oxidoreductase: Where are we now?. Free Radic Biol Med 2002; 33: 774–797
  • Harkness RA, McCreanor GM, Simpson D, MacFadyen IR. Pregnancy in and incidence of xanthine oxidase deficiency. J Inherit Metab Dis 1986; 9: 407–408
  • Herken H, Akyol O, Yilmaz HR, Tutkun H, Savas HA, Ozen ME, et al. Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment. Hum Psychopharmacol 2006; 21: 53–59
  • Herken H, Gurel A, Selek S, Armutcu F, Ozen ME, Bulut M, et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 2007; 38: 247–252
  • Hille R. Molybdenum-containing hydroxylases. Arch Biochem Biophys 2005; 433: 107–116
  • Ichida K, Amaya Y, Noda K, Minoshima S, Hosoya T, Sakai O, et al. Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase): structural analysis of the protein and chromosomal location of the gene. Gene 1993; 133: 279–284
  • Ichida K, Amaya Y, Kamatani N, Nishino T, Hosoya T, Sakai O. Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria. J Clin Invest 1997; 99: 2391–2397
  • Ichida K, Yoshida M, Sakuma R, Hosoya T. Two siblings with classical xanthinuria type 1: significance of allopurinol loading test. Intern Med 1998; 37: 77–82
  • Holthoff VA, Beuthien-Baumann B, Zündorf G, Triemer A, Lüdecke S, Winiecki P, et al. Changes in brain metabolism associated with remission in unipolar major depression. Acta Psychiatr Scand 2004; 110: 184–194
  • Jana A, Pahan K. Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis. J Neuroimmune Pharmacol 2007; 2: 184–193
  • Karabulut AB, Kafkasli A, Burak F, Gozukara EM. Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre-eclampsia. Cell Biochem Funct 2005; 3: 279–283
  • Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep 2003; 8: 365–370
  • Koutsilieri E, Scheller C, Tribl F, Riederer P. Degeneration of neuronal cells due to oxidative stress-microglial contribution. Parkinsonism Relat Disord 2002; 8: 401–406
  • Levartovsky D, Lagziel A, Sperling O, Liberman U, Yaron M, Hosoya T, et al. XDH gene mutation is the underlying cause of classical xanthinuria: a second report. Kidney Int 2000; 57: 2215–2220
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chemistry 1951; 193: 265–276
  • Lukash AI, Zaika VG, Kucherenko AO, Miliutina NP. Free radical processes and antioxidant system in depression and treatment efficiency. [Article in Russian] Zh Nevrol Psikhiatr Im S S Korsakova 2002; 102: 41–44
  • McCord JM. Oxygen-derived free radicals in postischemic tissue injury. New Engl J Med 1985; 312: 159–163
  • Meyer JH, Ginovart N, Boovariawala A, Sagrati S, Hussey D, Garcia A, et al. Elevated monoamine oxidase a levels in the brain:an explanation for the monoamine imbalance of major depression. Arch Gen Psychatry 2006; 63: 1209–1216
  • Michel TM, Nara K, Camara S, Koutsilieri E, Jecel JCh, Riederer P. Activity of xanthine oxidase in different brain regions of patients with Alzheimer's dementia – a post mortem study. World J Biol Psychiatry 2004a; 5: 86
  • Michel TM, Nara K, Camara S, Koutsilieri E, Thome J, Riederer P. Xanthine oxidase activity is decreased in distinct brain areas of patients with schizophrenic psychoses – a post mortem study. World J Biol Psychiatry 2004b; 5: 11
  • Michel TM, Thome J, Nara K, Martin D, Camara S, Weijers HG, et al. The role of oxidative stress in the pathogenesis of schizophrenic psychoses – superoxide dismutase (SOD)-coenzyme con-concentrations in post-mortem brain tissue of schizophrenic patients. J Neural Transm 2004c; 111: 1191–1201
  • Michel TM, Frangou S, Thiemeyer D, Camara S, Jecel J, Nara K, et al. Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder – a post-mortem study. Psychiatry Res 2007; 151: 145–150
  • Milak MS, Parsey RV, Keilp J, Oquendo MA, Malone KM, Mann J. Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch Gen Psychiatry 2005; 62: 397–408
  • Minoshima S, Wang Y, Ichida K, Nishino T, Shimizu N. Mapping of the gene for human xanthine dehydrogenase (oxidase) (XDH) to band p23 of chromosome 2. Cytogenet Cell Genet 1995; 68: 52–53
  • Murata T, Suzuki R, Higuchi T, Oshima A. Regional cerebral blood flow in the patients with depressive disorders. Keio J Med 2000; 49(Suppl)A112–113
  • Nishino T. The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury. J Biochem (Tokyo) 1994; 116: 1–6
  • Oda K, Okubo Y, Ishida R, Murata Y, Ohta K, Matsuda T, et al. Regional cerebral blood flow in depressed patients with white matter magnetic resonance hyperintensity. Biol Psychiatry 2003; 53: 150–156
  • Parashos IA, Tupler LA, Blitchington T, Krishnan KR. Magnetic-resonance morphometry in patients with major depression. Psychiatry Res 1998; 84: 7–15
  • Petrone WF, English DK, Wong K, McCord JM. Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma. Proc Natl Acad Sci USA 1980; 77: 1159–1163
  • Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998; 43: 315–319
  • Riederer P, Lange KW. Pathogenesis of Parkinson's disease. Curr Opin Neurol Neurosurg 1992; 5: 295–300
  • Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59–62
  • Roy RS, McCord JM. Oxy Radicals and their scavenger systems. Elsevier/North Holland, Amsterdam 1983
  • Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, et al. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 1989; 53: 692–697
  • Sakamoto N, Yamamoto T, Moriwaki Y, Teranishi T, Toyoda M, Onishi Y, et al. Identification of a new point mutation in the human xanthine dehydrogenase gene responsible for a case of classical type I xanthinuria. Hum Genet 2001; 108: 279–283
  • Saksela M, Lapatto R, Raivio KO. Xanthine oxidoreductase gene expression and enzyme activity in developing human tissues. Biol Neonate 1998; 74: 274–280
  • Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 2007; 22: 67–73
  • Saruwatari J, Nakagawa K, Shindo J, Tajiri T, Fujieda M, Yamazaki H, et al. A population phenotyping study of three drug-metabolizing enzymes in Kyushu, Japan, with use of the caffeine test. Clin Pharmacol Ther 2002; 72: 200–208
  • Schneider F, Gur RE, Mozley LH, Smith RJ, Mozley PD, Censits DM, et al. Mood effects on limbic flow correlate with emotional self-rating: a PET study with oxygen-15 labeled water. Psychiatry Res: Neuroimaging 1995; 61: 265–283
  • Sheline YI. 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol Psychiatry 2000; 48: 791–800
  • Sheline YI. Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 2003; 54: 338–352
  • Simmonds HA, Reiter S, Nishino T. Hereditary xanthinuria. The metabolic and molecular bases of inherited disease, CR Scriver, AL Beaudet, SW Sly, D Valle. McGraw-NeHill Inc, New York 1995; 1781–1797
  • Soares JC, Mann JJ. The anatomy of mood disorders-review of structural neuroimaging studies. Biol Psychiatry 1997; 41: 86–106
  • Takano H, Motohashi N, Uema T, Ogawa K, Ohnishi T, Nishikawa M, et al. Changes in regional cerebral blood flow during acute electroconvulsive therapy in patients with depression: positron emission tomographic study. Br J Psychiatry 2007; 190: 63–68
  • Terada LS, Willingham IR, Roasandich ME, Leff JA, Kindt GW, Repine JE. Generation of superoxide anion by brain endothelial cell xanthine oxidase. J Cell Physiol 1991; 148: 191–196
  • Terada LS, Guidot LS, Leff DM, Willingham IR, Hanley ME, Piermattei D, et al. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proc Natl Acad Sci USA 1992; 89: 3362–3366
  • Thome J, Gsell W, Rösler M, Kornhuber J, Frölich L, Hashimoto E, et al. Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease. Life Sci 1997; 60: 13–19
  • Vasic, N, Walter, H, Höse, A, Wolf, RC. 2008. Gray matter reduction associated with psychopathology and cognitive dysfunction in unipolar depression: A voxel-based morphometric study. J Affect Disor Epub
  • Wang JY, Wen LL, Huang YN, Chen YT, Ku MC. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Curr Pharm Des 2006; 12: 3521–3533
  • Winterbourn CC. Superoxide as an intracellular radical sink. Free Radic Biol Med 1993; 14: 85–90
  • Xu P, Huecksteadt TP, Harrison R, Hoidal JR. Molecular cloning, tissue expression of human xanthine dehydrogenase. Biochem Biophys Res Commun 1994a; 199: 998–1004
  • Xu P, Zhu XL, Huecksteadt TP, Brothman AR, Hoidal JR. Assignment of human xanthine dehydrogenase gene to chromosome 2p22. Genomics 1994b; 23: 289–291
  • Zoroglu SS, Armutcu F, Ozen S, Gurel A, Sivasli E, Yetkin O, et al. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci 2004; 54: 143–147
  • Zweier JL, Kuppusamy P, Lutty GA. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci USA 1988; 85: 4046–4050

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.